Sodium-glucose Cotransporter 2 Inhibitors and Ketoacidosis – Clinical Implications in the Treatment of Patients with Type 2 Diabetes

The use of sodium-glucose cotransporter 2 inhibitors is associated with an increased risk of diabetic ketoacidosis. This risk has been reported in particular in off-label use of these agents in type 1 diabetes, but reports of risks in type 2 diabetes patients also exist. In type 2 diabetes ketoacido...

Descripción completa

Detalles Bibliográficos
Autores principales: Stinkens, Kirsten, Mathieu, Chantal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Touch Medical Media 2016
Materias:
Diabetes Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813456/
https://www.ncbi.nlm.nih.gov/pubmed/29632585
http://dx.doi.org/10.17925/EE.2016.12.01.33

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813456/
https://www.ncbi.nlm.nih.gov/pubmed/29632585
http://dx.doi.org/10.17925/EE.2016.12.01.33

Ejemplares similares